Inventor
CHICARELLI MARK JOSEPH
US35 patents
⚠️ This page may combine multiple inventors who share the name “CHICARELLI MARK JOSEPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARRAY BIOPHARMA INC
17 patentsUS8697715B2Apr 15, 2014
Serine/threonine kinase inhibitors
ARRAY BIOPHARMA INC21 citations92
US9969727B2May 15, 2018
Pyrrolopyridines as kinase inhibitors
ARRAY BIOPHARMA INC6 citations84
US9365568B2Jun 14, 2016
Pyrrolopyridines as kinase inhibitors
ARRAY BIOPHARMA INC4 citations84
US8981085B2Mar 17, 2015
Pyrrolopyridines as kinase inhibitors
ARRAY BIOPHARMA INC10 citations84
US8758830B2Jun 24, 2014
Pyrrolopyridines as kinase inhibitors
ARRAY BIOPHARMA INC6 citations84
US9259470B2Feb 16, 2016
Serine/threonine kinase inhibitors
ARRAY BIOPHARMA INC6 citations83
US8022223B2Sep 20, 2011
2-aminopyridine analogs as glucokinase activators
ARRAY BIOPHARMA INC5 citations73
US9708290B2Jul 18, 2017
Serine/threonine kinase inhibitors
ARRAY BIOPHARMA INC3 citations72
US8022222B2Sep 20, 2011
Glucokinase activators
ARRAY BIOPHARMA INC7 citations72
US11634417B2Apr 25, 2023
Protein tyrosine phosphatase inhibitors
ARRAY BIOPHARMA INC2 citations70
US8362037B2Jan 29, 2013
2-aminopyridine analogs as glucokinase activators
ARRAY BIOPHARMA INC2 citations62
US11884664B2Jan 30, 2024
Protein tyrosine phosphatase inhibitors
ARRAY BIOPHARMA INC0 citations59
US10519126B2Dec 31, 2019
Serine/threonine kinase inhibitors
ARRAY BIOPHARMA INC0 citations51
US9079890B2Jul 14, 2015
Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives
ARRAY BIOPHARMA INC0 citations51
US8883828B2Nov 11, 2014
2-aminopyridine analogs as glucokinase activators
ARRAY BIOPHARMA INC0 citations51
US8354540B2Jan 15, 2013
2-aminopyridine analogs as glucokinase activators
ARRAY BIOPHARMA INC0 citations51
US12187721B2Jan 7, 2025
Protein tyrosine phosphatase inhibitors
ARRAY BIOPHARMA INC0 citations47
MIRATI THERAPEUTICS INC
7 patentsUS10125134B2Nov 13, 2018
KRas G12C inhibitors
MIRATI THERAPEUTICS INC43 citations96
US10689377B2Jun 23, 2020
KRas G12C inhibitors
MIRATI THERAPEUTICS INC16 citations85
US11267812B2Mar 8, 2022
KRAS G12C inhibitors
MIRATI THERAPEUTICS INC11 citations84
US11453683B1Sep 27, 2022
KRas G12D inhibitors
MIRATI THERAPEUTICS INC13 citations83
US10633381B2Apr 28, 2020
KRas G12C inhibitors
MIRATI THERAPEUTICS INC8 citations82
US11964989B2Apr 23, 2024
KRas G12D inhibitors
MIRATI THERAPEUTICS INC2 citations71
US11932633B2Mar 19, 2024
KRas G12C inhibitors
MIRATI THERAPEUTICS INC2 citations71
AICHER THOMAS DANIEL
3 patentsUS8212045B2Jul 3, 2012
Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
AICHER THOMAS DANIEL4 citations60
US8853409B2Oct 7, 2014
Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
AICHER THOMAS DANIEL1 citations50
US8431713B2Apr 30, 2013
2-aminopyridine derivatives as glucokinase activators
AICHER THOMAS DANIEL0 citations50